EW (STOCKS)
Edwards Lifesciences Corp
$86.890000
+1.780000 (+2.09%)
Prev close: $85.110000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Bernard J. Zovighian
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49,694.42M
- Employees
- 15,800
- P/E (TTM)
- 46.24
- P/B (TTM)
- 4.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
12
Strong Buy
19
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.78 | $0.75 | +0.0312 | +4.17% |
|
Dec 2025 (Q4)
|
$0.58 | $0.64 | -0.0563 | -8.85% |
|
Sep 2025 (Q3)
|
$0.67 | $0.61 | +0.0588 | +9.62% |
|
Jun 2025 (Q2)
|
$0.67 | $0.64 | +0.0282 | +4.39% |
Financial Statements
| Revenues | $6.30B |
| Benefits Costs and Expenses | $5.01B |
| Cost Of Revenue | $1.40B |
| Costs And Expenses | $5.01B |
| Gross Profit | $4.91B |
| Nonoperating Income/Loss | -$49.00M |
| Operating Expenses | $3.56B |
| Selling, General, and Administrative Expenses | $2.14B |
| Research and Development | $1.09B |
| Operating Income/Loss | $1.35B |
| Income/Loss From Continuing Operations After Tax | $1.07B |
| Income/Loss From Continuing Operations Before Tax | $1.30B |
| Income/Loss From Discontinued Operations Net Of Tax | $20.60M |
| Income Tax Expense/Benefit | $224.90M |
| Interest Income/Expense After Provision For Losses | -$23.40M |
| Interest Income/Expense Operating, Net | -$23.40M |
| Net Income/Loss | $1.09B |
| Net Income/Loss Attributable To Noncontrolling Interest | -$2.50M |
| Net Income/Loss Attributable To Parent | $1.10B |
| Net Income/Loss Available To Common Stockholders, Basic | $1.09B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $1.89 |
| Diluted Earnings Per Share | $1.88 |
| Basic Average Shares | 1,749,500,000 |
| Diluted Average Shares | 1,752,900,000 |
| Assets | $13.32B |
| Current Assets | $6.23B |
| Inventory | $1.12B |
| Prepaid Expenses | $135.70M |
| Other Current Assets | $4.97B |
| Noncurrent Assets | $7.09B |
| Fixed Assets | $1.82B |
| Intangible Assets | $1.23B |
| Other Non-current Assets | $4.04B |
| Liabilities | $2.99B |
| Current Liabilities | $1.41B |
| Accounts Payable | $181.10M |
| Wages | $265.40M |
| Other Current Liabilities | $962.50M |
| Noncurrent Liabilities | $1.58B |
| Equity | $10.33B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.33B |
| Liabilities And Equity | $13.32B |
| Net Cash Flow From Operating Activities | $1.36B |
| Net Cash Flow From Operating Activities, Continuing | $1.36B |
| Net Cash Flow From Investing Activities | -$891.00M |
| Net Cash Flow From Investing Activities, Continuing | -$891.00M |
| Net Cash Flow From Financing Activities | -$1.15B |
| Net Cash Flow From Financing Activities, Continuing | -$1.15B |
| Exchange Gains/Losses | -$18.90M |
| Net Cash Flow | -$701.30M |
| Net Cash Flow, Continuing | -$682.40M |
| Comprehensive Income/Loss | $1.13B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$2.50M |
| Comprehensive Income/Loss Attributable To Parent | $1.13B |
| Other Comprehensive Income/Loss | $33.20M |
| Other Comprehensive Income/Loss Attributable To Parent | $33.20M |